Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) is set to release its Q3 2025 earnings on Jan 31, 2025. The consensus ...

Operator Hello, and welcome to the fourth quarter and full year 2024 Teva Pharmaceutical Industries earnings conference call.

Shares of Teva Pharmaceutical Industries ( TEVA -13.66%) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p ...

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now producing increasingly personalised and sophisticated therapies, ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

The pharmaceutical industry is experiencing an exciting transformation, shifting from transactional partnerships to strategic ...

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Teva ...

Teva Pharmaceutical Industries Ltd. (TEVA) reported $4.23 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 5.1%. EPS of $0.71 for the same period ...

Our Bureau, Mumbai Thursday, January 30, 2025, 17:40 Hrs [IST] ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Sun Pharmaceutical Industries Ltd. 524715 shares inched down 0.79% to 1,761.80 Indian rupees Tuesday, on what proved to be an ...

Sun Pharmaceutical Industries Ltd. closed 11.40% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.